IssuerAnnouncementDetailsV2Portlet
Addendum Announcement from Jamjoom Pharmaceuticals Factory Co. in regards to the Board of Director's decision regarding the appointment of the Chairman and Vice-Chairman of the Board of Directors, formation of the Board committees, appointment of the Secretary of the Board and appointment of the Company’s representatives to the Capital Market Authority and the Saudi Exchange
Element List | Explanation |
---|---|
Introduction | Reference is made to the company’s announcement dated 01/07/2025 regarding the Board of Director's decision regarding the appointment of the Chairman and Vice-Chairman of the Board of Directors, formation of the Board committees, appointment of the Secretary of the Board and appointment of the Company’s representatives to the Capital Market Authority and the Saudi Exchange, In compliance with the Listing Rules and disclosure requirements, the company would like to provide a brief summary of the CVs of the appointed Audit Committee members that were not included in the previous announcement. |
Date of Posting the Previous Announcement of Development on Saudi Exchange’s Website | 2025-07-01 Corresponding to 1447-01-06 |
Hyperlink to the Previous Announcement | Click Here |
Change on the Development | A brief summary of the CVs of the appointed Audit Committee members is as follows: 1. Mr. Faris Al-Ghannam (Committee Chairman) – Independent Board Member: Faris AlGhannam is the CEO and Board Member of HSBC Saudi Arabia with a strong background in investment banking and capital markets in both Saudi Arabia and the UK. He serves on the Board of Directors at Jamjoom Pharma, as well as other leading companies and educational institutions. Faris holds an MBA from Rice University and a BSc in Accounting from Prince Sultan University. 2.Mr. Turki Alluhaid –Independent Non-Board Member: Mr. Turki is a Saudi Certified Public Accountant (SOCPA) and a certified public accountant in the US (CPA). He served as an Assurance Partner at Ernst & Young (EY) and also worked with EY Switzerland. He is currently the Office Managing Partner of Lyca. His range of experience covers audit and non-audit services in various sectors. 3.Mr. Marwan Al-Mubarak - Independent Non-Board Member: Marwan Almubarak is the Chief Audit Executive at Riyadh Metro and a seasoned audit leader with extensive experience in internal auditing, risk management, and governance across major Saudi organizations. He serves on several audit and governance committees in reputable institutions across Saudi Arabia. He holds a Master’s in Accounting from Cleveland State University and global certifications such as CIA, CISA, CRMA, and CFE. |
Financial Impact on the change | There is no financial impact resulting from this change. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.